IPSWICH, Mass. — New England Biolabs (NEB®), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Korea Ltd. (NEB Korea). The Republic of Korea is emerging as a global leader in the life science space, as a result of […]
Novel QIAcuity dPCR PanCancer Kits can detect rare mutations of EGFR and BRAF genes at the same time, while saving sample material, reducing time and cost New QIAseq Targeted RNA-seq Panel for T-cell Receptor allows targeted next-generation sequencing of T-cell receptors, increasing accuracy and sensitivity PAXgene® Urine Liquid Biopsy Set to enable non-invasive sample collection […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A), a global leader in life sciences and diagnostics, announced today its participation in the American Association for Cancer Research Annual Meeting (AACR). At the meeting, which will take place from April 5 to 10, 2024, in San Diego, CA, Agilent will highlight new cell analysis, genomics, digital pathology, […]
BOULDER, Colo. — Watchmaker Genomics, a provider of innovative solutions for molecular analysis, announced the launch of a high-purity RNase Inhibitor that is well-suited for a wide range of applications where maintaining RNA integrity is critical, including single-cell and single-nuclei sequencing, as well as pathogen detection. “We are pleased to bring our RNase Inhibitor to market,” said […]
Highly Sensitive and Multiplexed Assay for the Detection, Discrimination, and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600™ Droplet Digital™ PCR System HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.b), a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive […]
San Jose, California — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the Shasta™ Single-Cell System, an automated, high-throughput NGS solution with well-validated chemistries and intuitive bioinformatics tools that enables novel biomarker discovery for oncology research. This complete system allows researchers to mine more genomic and […]
The Chile-based Laboratory is using SOPHiA GENETICS’ platform to advance its research capabilities with blood disorders BOSTON, US and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Laboratorio Barnafi-Krause is live on the SOPHiA DDM™ Platform. Laboratorio Barnafi-Krause, located in Chile, has implemented SOPHiA […]
WALTHAM, MA. – Applied Biosystems TaqMan QSY2 probes enable multiplexing of research assays for up to 6 targets in a single qPCR reaction with industry-leading TaqMan performance Overview: Biopharma assay developers, as well as clinical research labs, are under constant pressure to save time and reduce costs, while also assuring accuracy and delivering reproducible results. This […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a new Human Pangenome Spike-in for the Twist Exome 2.0 panel developed to enable researchers to detect a more complete view of genetic variation […]
The Eppendorf Group and LabCentral have renewed their decade-long relationship for an additional five years. Strategically placed Eppendorf equipment and consumables at LabCentral enables reliable results for startups, contributing to scientific milestones to being reached quicker. Hamburg/Cambridge – The globally active Eppendorf Group proudly announces the 5-year partnership renewal with LabCentral, a renowned life sciences […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
